Postać rzutowo‑remisyjna stwardnienia rozsianego o ostrym przebiegu klinicznym. Opis przypadku
Abstract
Despite the great diversity of symptoms of multiple sclerosis (MS), in most cases, the course is quite typical. This study reports on the case of a patient with acute clinical course of multiplesclerosis, combined with the impairment of depression, drawing attention to the ways of dealing with the situation and providing an example of an individual approach to each patient. Appropriate
rehabilitation, intensive and correctly carried out, combined with medical treatment can bring a significant improvement in the patient’s health.
Key words: multiple sclerosis, clinical signs, acute clinical course
References
Cendrowski W.: Neuroepidemiologia kliniczna. Wrocław, Volumed 1997.
Chwastiak D.M. et al.: Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. “American Journal of Psychiatry” 2002, No. 159 (11), p. 1862–1868.
Correale J. et al.: Patterns of cytokine secretion by autoreactive proteolipid protein‑specific T cell clones during the course of multiple sclerosis. “Journal of Immunology” 1995, No. 154, p. 2959–2968.
Członkowska A.: Stwardnienie rozsiane – współczesna diagnostyka i leczenie. „Przewodnik Lekarza” 2003, nr 6 (1), s. 6–15.
Hafler A., Compston A.: Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study. „New England Journal of Medicine” 2007, No. 357, p. 851–862.
Herndon R.M.: Multiple Sclerosis: Immunology, Pathology and Pathophysiology. New York, Demos Medical Publishing 2003.
Kowal P.: „Epidemiologia stwardnienia rozsianego na terenie 4 województw zachodniej Polski”. Praca doktorska. Poznań, Akademia Medyczna 1987.
Levin L.I., Munger K.L., Rubertone M.V. et al.: Temporal relationship between elevation of epstein‑barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. „JAMA” 2005, p. 2496–2500.
Losy J.: Rola czynników immunologicznych i zapalnych w patogenezie stwardnienia rozsianego. „Polski Przegląd Neurologiczny” 2009, t. 5, nr 4, s. 159–165.
Lucchinetti C. et al.: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. “Annals of Neurology” 2000, No. 47, p. 707–717.
Muelen V., Katz M.: The proposed viral etiology of multiple sclerosis and related demyelinating diseases. In: Multiple sclerosis. Eds. C.S. Raine, H.F. McFarland, W.W. Tourtellotte. London, Chapman & Hall Medical 1997.
Polman Ch.H. et al.: Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria. “Annals of Neurology” 2011, No. 69, s. 292–302.
Potemkowski A.: Stwardnienie rozsiane w świecie i w Polsce – ocena epidemiologiczna. „Aktualności Neurologiczne” 2009, nr 9 (2), s. 91–97.
Prosperini L. et al.: Visuo‑proprioceptive training reduces risk of falls in patients with multiple sclerosis. “Multiple Sclerosis Journal” 2010, No. 16 (4), p. 491–499.
Stinissen P., Raus J., Zhang J.: Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. “Critical Reviews in Immunology” 1997, No. 17, p. 33–75.
Szwed M.: Mitoksantron – antybiotyk antrachinonowy o aktywności przeciwnowotworowej stosowany w leczeniu stwardnienia rozsianego. „Postępy Higieny i Medycyny Doświadczalnej” 2014, nr 68, s. 198–208.
Tefertiller C. et al.: Efficacy of rehabilitation robotics for walking training in neurological disorders: A review. “Journal of Rehabilitation Research” 2011, No. 48 (4), p. 387–416.
Tutaj M., Szczepanik M.: Mechanizmy regulacji odpowiedzi immunologicznej w modelu stwardnienia rozsianego u myszy. „Postępy Higieny i Medycyny Doświadczalnej” 2006, nr 60, s. 571–583.
Vergaro E. et al.: Adaptive robot training for the treatment of incoordination in Multiple Sclerosis. “Journal of NeuroEngineering and Rehabilitation” 2010, No. 7, p. 37.
Wender M. et al.: Epidemiology of multiple sclerosis in western Poland – a comparison between prevalence rates in 1965 and 1981. “Acta Neurologica Scandinavica” 1985, No. 72, p. 210–217.
Katedra Farmakologii, Śląski Uniwersytet Medyczny
Katedra Farmakologii, Śląski Uniwersytet Medyczny
Gliwickie Centrum Medyczne
Uniwersyteckie Centrum Kliniczne im. prof. Kornela Gibińskiego, Śląski Uniwersytet Medyczny
Uniwersyteckie Centrum Kliniczne im. prof. Kornela Gibińskiego, Śląski Uniwersytet Medyczny
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The Copyright Owners of the submitted texts grant the Reader the right to use the pdf documents under the provisions of the Creative Commons 4.0 International License: Attribution-Share-Alike (CC BY SA). The user can copy and redistribute the material in any medium or format and remix, transform, and build upon the material for any purpose.
1. License
The University of Silesia Press provides immediate open access to journal’s content under the Creative Commons BY-SA 4.0 license (http://creativecommons.org/licenses/by-sa/4.0/). Authors who publish with this journal retain all copyrights and agree to the terms of the above-mentioned CC BY-SA 4.0 license.
2. Author’s Warranties
The author warrants that the article is original, written by stated author/s, has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author/s.
If the article contains illustrative material (drawings, photos, graphs, maps), the author declares that the said works are of his authorship, they do not infringe the rights of the third party (including personal rights, i.a. the authorization to reproduce physical likeness) and the author holds exclusive proprietary copyrights. The author publishes the above works as part of the article under the licence "Creative Commons Attribution-ShareAlike 4.0 International".
ATTENTION! When the legal situation of the illustrative material has not been determined and the necessary consent has not been granted by the proprietary copyrights holders, the submitted material will not be accepted for editorial process. At the same time the author takes full responsibility for providing false data (this also regards covering the costs incurred by the University of Silesia Press and financial claims of the third party).
3. User Rights
Under the CC BY-SA 4.0 license, the users are free to share (copy, distribute and transmit the contribution) and adapt (remix, transform, and build upon the material) the article for any purpose, provided they attribute the contribution in the manner specified by the author or licensor.
4. Co-Authorship
If the article was prepared jointly with other authors, the signatory of this form warrants that he/she has been authorized by all co-authors to sign this agreement on their behalf, and agrees to inform his/her co-authors of the terms of this agreement.
I hereby declare that in the event of withdrawal of the text from the publishing process or submitting it to another publisher without agreement from the editorial office, I agree to cover all costs incurred by the University of Silesia in connection with my application.